Tariff-driven disruptions in regulatory compliance

From Yahoo Finance: 2025-05-06 11:22:00

Tariffs impact medical device industry compliance, causing disruptions in supply chains and triggering additional regulatory requirements. Changes in materials or manufacturing processes may necessitate new approvals, delaying products and increasing costs. Companies like Medtronic and Abbott Laboratories feel the effects, requiring adjustments in multiple jurisdictions and straining compliance resources. Balancing innovation, cost containment, and regulatory integrity becomes complex in the face of tariffs.



Read more at Yahoo Finance: Tariff-driven disruptions in regulatory compliance